News
Are There Contraindications to Switching From Intramuscular to Subcutaneous Depo-Provera? Laurie E. Scudder, MS, NP-C. Disclosures. December 16, 2008. Question ...
The US Food and Drug Administration (FDA) has approved a furosemide preparation (Furoscix, scPharmaceuticals) intended for subcutaneous self-administration by outpatients with chronic heart ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback